Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Top Gainers & Losers on Feb 26: Tejas Networks, KSB, Mankind Pharma, Tata Motors, Finolex Cables among top gainers
The Indian stock market remained largely unchanged on February 26, with the Nifty 50 up 0.06% at 25,496 and the S&P BSE Sensex flat at 82,248. Broader markets showed mixed results, while US stocks rallied on Nvidia's strong earnings, boosting Asian markets as well.
Taking Stock: Markets rally for 5th straight day; Sensex, Nifty soar 4% on ceasefire deal
Nearly 100 stocks touched their 52-week high on the BSE, including Adani Energy, Titan Company, ABB India, Natco Pharma, SAIL, Anand Rathi, Aurobindo Pharma, Godawari Power, Granules India, CCL Products, among others.
Taking Stock: Markets extend losses; Nifty slips below 24,200, Sensex declines 852 pts
Biggest Nifty losers were Trent, M&M, Shriram Finance, SBI Life Insurance, Tech Mahindra, while gainers included Dr Reddy's Labs, Cipla, Jio Financial, Adani Enterprises, Apollo Hospitals.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.
Granules India looks for M&A as it expands beyond the US, deepens focus on complex generics
To fund this transition and strengthen balance sheet, the company completed a Rs1,762.50 crore capital-raise in February 2026.
Broader markets outshine benchmarks; Smallcaps extend weekly winning run
Most of the sectoral indices ended in the green, with Nifty realty index surged nearly 8 percent, Nifty Pharma index rose 3 percent, Nifty Healthcare index added 3 percent, while Nifty Capital Market and Defence indices added nearly 2 percent each.
LIVE: Nifty fails to hold 24,000; metals outperform | Closing Bell
Markets ended lower, snapping a two-day winning streak, with benchmark indices pressured by weakness in financials and select heavyweight stocks. The Sensex declined over 300 points, while the Nifty failed to hold above the crucial 24,000 mark. Market breadth remained weak, with decliners outnumbering advancers by nearly two-to-one on the BSE, reflecting broad-based selling. Investor caution was also evident as the India VIX climbed around 5%, indicating a pickup in volatility expectations. On the sectoral front, pharma and metal stocks bucked the trend, with the Metal index snapping a three-session losing streak. Banking stocks remained under pressure, dragging the Bank Nifty below the 58,000 mark. Among the Nifty 50 gainers, Dr Reddy's, Max Healthcare and Trent led the advances, while Kotak Mahindra Bank, Mahindra & Mahindra and IndiGo were among the biggest losers of the session.
Taking Stock: Sensex, Nifty end flat ahead of RBI policy; consumer durables, capital goods shine
More than 120 stocks touched their 52-week high on the BSE, including Cemindia Projects, Nippon Life India Asset Management, Jindal Saw, HFCL, Syrma SGS, Laurus Labs, Polycab, Vodafone Idea, Federal Bank, IFCI, JK Bank, Welspun Corp, RBL Bank, among others.